NRX Pharmaceuticals Maintained at Buy by Ascendiant Capital
Ascendiant Capital has maintained its Buy rating on NRX Pharmaceuticals.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.